What You Should Know:

您应该知道：

– H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.

–H1是医疗保健专业人员、临床试验信息和生命科学研究的首选资源，它宣布推出其对话AI工具GenosAI Pro。

– The conversational AI tool empowers pharmaceutical companies to streamline workflows, enhance data-driven decision-making, and optimize clinical trial processes within the Trial Landscape platform.

–对话人工智能工具使制药公司能够在试验环境平台内简化工作流程，增强数据驱动的决策，并优化临床试验流程。

Transforming Clinical Trial Design

改变临床试验设计

Building upon the success of GenosAI Lite, GenosAI Pro leverages ChatGPT Enterprise technology to deliver unprecedented capabilities. Secured within H1’s infrastructure, this next-generation tool transforms complex data into visual insights and actionable deliverables, accelerating and simplifying:

在GenosAI Lite成功的基础上，GenosAI Pro利用ChatGPT企业技术提供前所未有的功能。在H1的基础设施中，这一新一代工具将复杂的数据转化为可视的见解和可操作的交付成果，从而加速和简化了：

Diversity plan & feasibility analysis: Craft inclusive trial designs by identifying optimal locations, sponsors, and HCPs with relevant diversity data.Healthcare provider (HCP) & site biobook creation: Streamline information gathering and biobook development with AI-powered summaries.Presentation slide generation: Quickly build compelling decks for trial design meetings or diversity plan presentations..

多样性计划和可行性分析：通过确定最佳地点，赞助商和HCP以及相关的多样性数据来进行包容性试验设计。医疗保健提供者（HCP）和网站biobook创建：通过人工智能提供的摘要简化信息收集和biobook开发。演示幻灯片生成：快速构建引人注目的平台，用于试验设计会议或多样性计划演示。。

“GenosAI Pro marks a significant leap forward in applying the power of generative AI to clinical research, offering unmatched insights and efficiencies. It exemplifies H1’s commitment to advancing healthcare through innovative technologies,” said H1’s CEO and co-founder Ariel Katz. “Empowering users to instantly and seamlessly access profound insights from Trial Landscape data, GenosAI Pro is transforming the utilization of clinical trial data on a daily basis.”.

H1首席执行官兼联合创始人阿里尔·卡茨（ArielKatz）表示：“GenosAI Pro标志着在将生成人工智能的力量应用于临床研究方面取得了重大飞跃，提供了无与伦比的见解和效率。它体现了H1通过创新技术推进医疗保健的承诺。”。“GenosAI Pro使用户能够立即无缝地从试验数据中获得深刻的见解，正在改变临床试验数据的日常利用。”。